"Our mission is not only to provide critical resources and education but also to raise awareness about the importance of preventing diabetes complications such as heart disease, nerve damage, and ...
Investing.com -- The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s ...
Crisugabalin provides significant improvement in average daily pain score and shows promise as a postherpetic neuralgia treatment.
A brain mapping study funded by the NIH reveals which cell types may be the first to be affected. New research funded by the ...